Showing 571-580 of 3101 results for "".
Optical Coherence Tomography & Neurology
https://practicalneurology.com/diseases-diagnoses/imaging-testing/optical-coherence-tomography-neurology/31853/Going beyond the ophthalmoscope for multiple sclerosis, neuromyelitis optica spectrum disorder, and “microscopic Hollenhorst plaques.”Multiple Sclerosis Minute: The Central Vein Sign in Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-the-central-vein-sign-in-diagnosis-of-multiple-sclerosis/31676/More accurate diagnosis is needed for multiple sclerosis and the central vein sign may be the needed imaging biomarker.Familial Cerebral Cavernous Malformation
https://practicalneurology.com/diseases-diagnoses/imaging-testing/familial-cerebral-cavernous-malformation/31915/In this case of familial vascular malformation, multiple calcified intracranial lesions masqueraded as neurocysticercosis.OnabotulinumtoxinA for Trigeminal Neuralgia Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxina-for-trigeminal-neuralgia-treatment/32127/There is a growing body of evidence suggesting that onabotulinumtoxinA is a safe and effective treatment for trigeminal neuralgia.Improving Beyond Fewer Headache Days: Redefining Success in Migraine Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/improving-beyond-fewer-headache-days-redefining-success-in-migraine-treatment/39912/Headache Horizons: The Promise of Dual Treatment for Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-promise-of-dual-treatment-for-migraine/31843/Use of 1 drug for preventive and acute migraine treatment represents a paradigm shift.Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals
Update on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/32129/Neuromodulation devices are effective in primary headache management, present low risk, and have minimal to no adverse events but require an understanding of how they can be integrated into the therapeutic armamentarium.